Both recalls are categorized as Class 2, which the FDA designates for issues that have the potential to “cause temporary or medically reversible adverse health consequences."

eMurmer's new Heart AI software was designed to detect both the presence and absence of heart murmurs in digital stethoscope recordings. It can also gather critical hemodynamic data, helping care teams gain a better understanding of the patient's cardiovascular health. 

According to a report from Myrtle Beach Online, a lawsuit has been filed accusing the optometrist of emotional manipulation and domestic abuse. The complaint comes after she filed for divorce. 

Backed by private equity investors at Grovecourt Capital Partners, the Florida firm is buying National Radiology Solutions for an undisclosed sum.

A past president of the RSNA and Rutgers RO chair, Bruce Haffty, MD, will serve as the college's new chief medical officer for radiation oncology research.

More than 75% of U.S. nurses have high hopes in generative AI’s promise for improving productivity. But less than half feel prepared to use it effectively.

The company announced the funding on Monday, citing the U.S. Food and Drug Administration’s clearance of its CT:VQ platform as the driver. 

The Federal Trade Commission said it's seeking a resolution with Cigna, the parent company of the pharmacy benefit manager. The agency filed an antitrust complaint against Express Scripts, Optum Rx and CVS Caremark in 2024, alleging the "Big Three" PBMs use anticompetitive tactics to control the insulin supply chain within their vertical.